Chairs: Amy Cain & Maria Halili
Preclinical assessment of a non-M protein group A streptococcal vaccine demonstrating protective efficacy in the non-human primate model of pharyngitis. (93466)
8:30 AM
Antibody-antibiotic conjugate for treatment of melioidosis (94275)
8:45 AM
Hollow Fibre Infection Model Assessment of Melioidosis Therapeutics (94205)
9:00 AM
Development towards a Chlamydia pecorum vaccine for koalas; Vaccine longevity, population effects and future directions (94059)
9:15 AM
Re-sensitising Streptococcus pneumoniae to tetracycline and macrolide antibiotics with metal ionophores (93510)
9:30 AM
Novel EptA inhibitors increase the susceptibility of N. gonorrhoeae to killing by innate immune defenses (93826)
9:40 AM
Insights into the mechanisms of daptomycin-loaded cubosomes in synergistically killing methicillin-resistant Staphylococcus aureus (93795)
9:50 AM